These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 10089634

  • 1. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA, Garat Barredo JM, Villavicencio Mavrich H.
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results.
    Chancellor MB, Atan A, Rivas DA, Watanabe T, Tai HL, Kumon H.
    Tech Urol; 1999 Dec; 5(4):191-4. PubMed ID: 10591256
    [Abstract] [Full Text] [Related]

  • 3. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
    Unsal A, Cimentepe E.
    Scand J Urol Nephrol; 2004 Dec; 38(3):240-2. PubMed ID: 15204379
    [Abstract] [Full Text] [Related]

  • 4. [Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh, Gorbachev AG, Borovets SIu, Belousov VIa, Kuz'min IV.
    Urologiia; 2005 Dec; (5):25-6. PubMed ID: 16281835
    [Abstract] [Full Text] [Related]

  • 5. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
    Ho DR, Lin WY, Wu CF, Shee JJ, Huang YC, Chen CS.
    BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of oral desmopressin therapy in posterior urethral valve patients with polyuria and detection of factors affecting the therapy.
    Naghizadeh S, Kefi A, Dogan HS, Burgu B, Akdogan B, Tekgul S.
    Eur Urol; 2005 Nov; 48(5):819-25. PubMed ID: 15998564
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of intranasal desmopressin in the treatment of nocturia due to nocturnal polyuria].
    Terada N, Arakaki R, Okada Y, Kitahara M, Kaneko Y, Omori K, Nishimura K.
    Hinyokika Kiyo; 2005 Mar; 51(3):151-4. PubMed ID: 15852666
    [Abstract] [Full Text] [Related]

  • 8. Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia.
    Schulman CC, Lock TM, Buzelin JM, Boeminghaus F, Stephenson TP, Talja M, European Tamsulosin Study Group.
    J Urol; 2001 Oct; 166(4):1358-63. PubMed ID: 11547074
    [Abstract] [Full Text] [Related]

  • 9. A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily.
    Tsuritani S, Nozaki T, Okumura A, Kimura H, Kazama T.
    Urol Int; 2010 Oct; 85(1):80-7. PubMed ID: 20516676
    [Abstract] [Full Text] [Related]

  • 10. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P, Wu Z, Gao J.
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [Abstract] [Full Text] [Related]

  • 11. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.
    Yokoyama T, Kumon H, Nasu Y, Takamoto H, Watanabe T.
    Int J Urol; 2006 Jul; 13(7):932-8. PubMed ID: 16882058
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T.
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [Abstract] [Full Text] [Related]

  • 13. [Long-term efficacy of naftopidil for treatment of lower urinary tract symptoms with benign prostatic hyperplasia].
    Akasaka T, Funaki H, Hirano S, Ohinata M, Fujishima M, Kudou T, Suzuki A, Iinuma M.
    Hinyokika Kiyo; 2003 Apr; 49(4):189-93. PubMed ID: 12784711
    [Abstract] [Full Text] [Related]

  • 14. [Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia].
    Sugino Y, Fukuzawa S, Takeuchi H, Taki Y, Hashimura T, Soeda T, Araki I.
    Hinyokika Kiyo; 2003 Aug; 49(8):445-9. PubMed ID: 14518379
    [Abstract] [Full Text] [Related]

  • 15. [Safety ov benign prostatic hyperplasia treatment with alpha-adrenoblocker dalphas].
    Loran OB, Pushkar' DIu, Rasner PI.
    Urologiia; 2000 Aug; (2):3-5. PubMed ID: 11186726
    [Abstract] [Full Text] [Related]

  • 16. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
    Yokota T, Honda K, Tsuruya Y, Nomiya M, Yamaguchi O, Gotanda K, Constantinou CE.
    Prostate; 2004 Feb 01; 58(2):156-63. PubMed ID: 14716740
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effect of harnal and proscar in treating benign prostatic hyperplasia].
    Tang ZY, Peng KL, Ding J, Zu XB, Qi L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec 01; 30(6):708-10. PubMed ID: 16708816
    [Abstract] [Full Text] [Related]

  • 18. [Clinical and urodynamic evaluation of efficacy of conservative treatment of urination disorders in patients with benign prostate hyperplasia].
    Danilov VV, Danilova TI, Danilov VV, Danilov VV.
    Urologiia; 2013 Dec 01; (5):55-8. PubMed ID: 24437242
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. A double-blind study.
    Månsson W, Sundin T, Gullberg B.
    Scand J Urol Nephrol; 1980 Dec 01; 14(2):139-41. PubMed ID: 6163201
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y, Zhao XF, Li HZ, Wang W, Zhang Y, Xiao H, Zhang X.
    Chin Med J (Engl); 2007 Mar 05; 120(5):370-4. PubMed ID: 17376305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.